User banner image
User avatar
  • admin

Posts

aulumu Launches G05 Pro Multi-Function Mag Kickstand

A compact magnetic stand engineered as an everyday urban utility toolkit SHENZHEN, China, June 1, 2026 /PRNewswire/ — aulumu, the design-driven accessories brand renowned for blending...

Drake International Launches Drake Force for Good Day, a Global Commitment to Building the Workforce of Tomorrow

On its 75th anniversary, the global talent management and workforce advisory firm declares that the organizations which will win the AI era are not those...

Drake International Launches Drake Force for Good Day, a Global Commitment to Building the Workforce of Tomorrow

On its 75th anniversary, the global talent management and workforce advisory firm declares that the organizations which will win the AI era are not those...

PUDU Embodied Unveils the Next-Generation PUDU D7: Opening a New Chapter for Industrial Semi-Humanoid Robotics

SHENZHEN, China, June 1, 2026 /PRNewswire/ — Pudu Robotics, a global leader in service robotics, today announced the launch of its new PUDU D7, its...

Ranok Therapeutics Announces Positive Interim Phase 1 Data Of Its KRAS G12D Inhibitor RNK08954 In Patients With KRAS G12D-Mutated Metastatic Non-Small Cell Lung Cancer Presented At ASCO 2026

Clinically Meaningful Overall Antitumor Activity, with ORR of 42.9% and DCR of 95.9% across all evaluated dose levels in heavily pretreated patients. Enhanced Clinical Activity...

“It CAN’T happen to Me!” How to drive impactful messaging

We know life is sometimes a gamble. The news tells us so every day. We don’t doubt the risk; we just assume lightning strikes somewhere...

BriaCell Therapeutics Announces Pricing of Offering

PHILADELPHIA and VANCOUVER, British Columbia, May 31, 2026 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a...

Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026

ROCKVILLE, Md. and SUZHOU, China, May 31, 2026 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company...

Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026

ROCKVILLE, Md. and SUZHOU, China, May 31, 2026 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company...

Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026

ROCKVILLE, Md. and SUZHOU, China, May 31, 2026 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company...